 | Drug Safety Update MHRA June 2018.pdf (186KB) | 03/07/2018 | Download |
| | Drug safety Update MHRA June 2018 | |
| MHRA Drug Safety Update May 2018.pdf (153KB) | 04/06/2018 | Download |
| | Valproate medicines (Epilim▼, Depakote▼): Pregnancy Prevention Programme materials online. Braltus (tiotropium): risk of inhalation of capsule if placed in the mouthpiece of the inhaler. | |
| Drug Safety Update MHRA April 2018 (267KB) | 24/04/2018 | Download |
| | Drug Safety Update MHRA April 2018 | |
| MHRA DSU March 18-PDF.pdf (274KB) | 09/03/2018 | Download |
| | Drug Safety Update MHRA March 2018. daclizumab, esmya, headlice | |
| Drug Safety Update MHRA February 2018 PDF.pdf (278KB) | 13/02/2018 | Download |
| | Misoprostol vaginal delivery system (Mysodelle): reports of excessive uterine contractions (tachysystole) unresponsive to tocolytic treatment. Mycophenolate mofetil, mycophenolic acid: updated... | |
| Drug Safety Update January 2018.pdf (301KB) | 09/01/2018 | Download |
| | Daclizumab (Zinbryta▼) and risk of severe liver injury. Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions. Drug-name confusion: reminder to be vigilant for... | |
| Drug Safety Update MHRA December 2017 (421KB) | 15/12/2017 | Download |
| | Cladribine (Litak, Leustat) for leukaemia, Gadolinium-containing contrast agents, Radium-223 dichloride (Xofigo▼), Eluxadoline (Truberzi ▼): | |
| Drug Safety Update MHRA November 2017 pdf. (357KB) | 27/11/2017 | Download |
| | Gentamicin: potential for histamine-related adverse drug reactions with some batches, Quinine: reminder of dose-dependent QT-prolonging effects; updated interactions, Oral tacrolimus products:... | |
| Drug Safety Update MHRA October pdf.pdf (246KB) | 27/10/2017 | Download |
| | Methylprednisolone inj medicines containing lactose
Gabapentin: risk of severe respiratory depression
Clozapine: reminder of potentially fatal risk of intestinal obstruction, | |
| Drug safety Update MHRA Sept-pdf.pdf (230KB) | 27/10/2017 | Download |
| | Miconazole (Daktarin) OTC oral gel contra-indications in patients taking warfarin.
Loperamide: reports of serious cardiac adverse reactions with high doses of loperamide associated with abuse or... | |
| Drug Safety Update MHRA August PDF.pdf (260KB) | 27/10/2017 | Download |
| | Ibrutinib (Imbruvica▼): reports of ventricular tachyarrhythmia;
risk of hepatitis B reactivation and of opportunistic infections
Corticosteroids: risk of central serous chorioretinopathy with... | |
| Drug Safety Update MHRA July 2017 PDF.pdf (229KB) | 26/07/2017 | Download |
| | Daclizumab (Zinbryta▼) and risk of severe liver injury, Bendamustine (Levact, Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): reports of organ transplant rejection | |
